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Abstract We have isolated a novel cDNA, vesl, that was 
induced during convulsive seizure in the rat hippocampus. The 
vesl gene encodes a protein of 186 amino acids that has 
significant homology to the EVH1 domain of the VASP/Ena 
family of proteins implicated in the control of microfilament 
dynamics. The expression of vesl mRNA was induced in the 
granule cell layer during persistent long-term potentiation (LTP) 
of the dentate gyrus in an NMDA receptor-dependent manner. 
Furthermore, vesl mRNA was expressed at a high level during 
hippocampal synaptogenesis. We suggest that the Vesl protein 
may be involved in the structural changes that occur at synapses 
during long-lasting neuronal plasticity and development. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Behavioral and pharmacological studies have revealed that 
memory has at least two distinct components, short-term and 
long-term memory. Long-term memory differs from short-
term memory in that it requires gene expression and protein 
synthesis at a critical period during and/or shortly after the 
learning experience (for review, [3]). Various protein synthesis 
inhibitors block the prolonged storage of memory without 
affecting short-term memory, in both vertebrates and inverte-
brates. This suggests that gene products synthesized during 
learning switch the stored information from a short-lasting 
labile form to a long-lasting stable form [4]. 
Activity-dependent changes in the strength of synaptic 
transmission have been considered to provide a plausible cel-
lular basis for learning and memory. Long-term potentiation 
(LTP) is a typical form of synaptic plasticity, in which elec-
*Corresponding author. Fax: (81) (427) 24-6314. 
E-mail: kaoru@libra.ls.m-kagaku.co.jp 
Abbreviations: LTP, long-term potentiation; PTZ, pentylenetetrazol; 
bp, base pair(s); CHX, cycloheximide; kb, kilobase(s); ORF, open 
reading frame; NMDA, JV-methyl-D-aspartate; HFS, high-frequency 
stimulation; LFS, low-frequency stimulation; fEPSP, field excitatory 
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Some of the results described in this work have been published in 
abstract form, in which vesl was called Ti3 [1]. The nucleotide sequence 
data reported in this paper will appear in the DDBJ, EMBL and 
GenBank nucleotide sequence databases with the following accession 
number: AB003726. During preparation of the manuscript, we have 
noted that Vesl (also called Homer) selectively interacts with 
metabotropic glutamate receptors [2]. 
trical stimulation causes a long-lasting increase in synaptic 
efficacy [5]. Importantly, LTP in the hippocampus appears 
to have two distinct phases. The early phase, which persists 
~ 3 h, is independent of macromolecule synthesis, whereas the 
late phase, which lasts for several hours in vitro and even for 
weeks in vivo, is prevented by pharmacological inhibition of 
protein and RNA synthesis, without any effects on the early 
phase [6-10]. These results strongly suggest that a particular 
set of genes, whose expression is induced after neural activity, 
play crucial roles in the prolonged maintenance of plastic 
changes in synaptic efficacy. Recent studies have identified a 
number of genes that are induced following a high-frequency 
stimulus (HFS) that elicits the late phase of LTP [11-20]. A 
major class of genes identified so far encodes transcription 
factors such as NGFI-A (also called Zif268, Krox24 and 
Egrl), c-Fos, Krox20 (Egr2), and Egr3 [11,12,16,20], support-
ing the hypothesis that altered gene expression is a prerequi-
site for the prolonged maintenance of LTP. In addition to 
these regulatory proteins, the late phase of LTP is accompa-
nied by the induction of effector proteins such as activin [3A 
and Arc [18,19,21]. One of the most important functions of 
effector proteins is thought to be their contribution to the 
reorganization of the neural circuit, which they achieve by 
either strengthening the pre-existing synaptic connections or, 
perhaps, by promoting the formation of new synaptic connec-
tions. 
Here we report the identification of a novel plasticity-regu-
lated gene, vesl (KASP/£ha-related gene upregulated during 
.seizure and LTP). Structural analysis of the cDNA revealed 
that the N-terminal half of the predicted amino acid sequence 
had similarity to the EVH1 domain of the VASP/Ena family 
of proteins. This class of protein is enriched in focal adhesion 
and has been implicated in actin dynamics [22,23]. Prolonged 
maintenance of neuronal plasticity is considered to rely on, at 
least partly, the formation of new synaptic connections, which 
requires neurite outgrowth. Neurite outgrowth at growth 
cones is carried out through actin polymerization at filopodia. 
We suggest that Vesl may contribute to the perpetuation of 
the plastic change in synaptic transmission by regulating actin 
polymerization. 
2. Materials and methods 
2.1. mRNA differential display screening of neural activity-dependent 
genes 
The screening was performed essentially as described previously 
[19,20]. 
2.2. Surgical procedure and electrophysiology 
Adult male Wistar rats (12-18 weeks old, 40(M150 g) were deeply 
anesthetized with pentobarbital (50 mg/kg, i.p.) and placed on a ster-
eotaxic apparatus. The skull was exposed and electrodes were im-
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planted through burr holes in the skull. Stimulating and recording 
electrodes were made of epoxylite-coated tungsten wire (100 urn di-
ameter). The bipolar stimulating electrode was positioned unilaterally 
to the perforant pathway at stereotaxic coordinates of 8.0 mm poste-
rior, 4.5 mm lateral, and 4.5 mm inferior to bregma. The bipolar 
electrode consisted of two parallel strands of the same wire. A mo-
nopolar recording electrode was inserted ipsilaterally into the hilus of 
the dentate gyrus, 4.0 mm posterior, 2.5 mm lateral, and 3.8 mm 
inferior to bregma. The depth of the two electrodes was adjusted by 
monitoring the field potential so that the slope of the field excitatory 
postsynaptic potential (fEPSP) was maximal. The electrodes were con-
nected to miniature sockets and they were fixed to the skull by dental 
cement (Shofu). Stainless anchor bolts screwed into the skull served as 
reference electrode and earth. At the end of surgery, the sutured 
wound margin was sterilized and antibiotic (Teramycin, 20 mg/kg, 
Pfizer) was injected intramuscularly. Each animal was cared for, 
and allowed to recover in individual home cage. Food and water 
were available ad libitum. The colony room had a 12/12 h light/ 
dark cycle and was maintained at 18±2°C. 
LTP experiments were carried out under urethane anesthesia. Fol-
lowing a 2- to 3-week recovery period, 25 animals were anesthetized 
with urethane (1.2 g/kg, i.p.) and an input-output curve was deter-
mined. The current intensity of the test pulses (0.1 ms duration) was 
set at 40% of the stimulation current that evoked a maximal field 
population spike. This stimulation intensity was used for test and 
tetanic stimuli. All the electro-stimuli were constant-current, mono-
phasic square-wave pulses. Thirteen animals were given high-fre-
quency tetanic trains to evoke LTP following a 15-min control base-
line recording. An NMDA receptor antagonist, MK801 (5 mg/kg i.p. 
injection, Research Biochemical International), was preinjected into 
the other 6 animals, 45 min prior to the first tetanic train. Tetanus 
consisted of 5 trains of high-frequency stimulation (HFS) (each train, 
400 Hz for 1 s, 0.25 ms pulse width) delivered at 2-min inter-train 
intervals. Both the fEPSP slope and the amplitude of the population 
spike were monitored as an index of LTP. Test pulse (0.1 ms dura-
tion) was delivered at 90-s intervals (low-frequency stimulation, LFS). 
The evoked responses were amplified, digitized at 50 kHz and stored 
sequentially on computer discs (NEC PC9801 DX) for off-line anal-
ysis. The initial fEPSP slopes were displayed as a percentage of the 
mean value obtained during the 15 min period just before tetanus. 
Animals were fixed by cardiac perfusion for in situ hybridization 
under deep urethane anesthesia either 45 min (HFS, n = 5; 
MK801+HFS, « = 2) or 3 h (HFS, w = 8; MK801+HFS, n = 4) after 
the first train of tetanic stimulation. Six chronically implanted ani-
mals, which served as a control, were treated in the same way as the 
LTP group, except that they did not receive HFS. These animals were 
fixed 1 h or 3 h 15 min after the recording of the first evoked response 
(n = 2 and n = 4, respectively). 
that the levels of a set of cDNAs were increased by neural 
activity [19,20]. One of the PCR fragments (180 bp), amplified 
with the pair of primers, T12MT (M, a mixture of A, C and 
G) and 5'-GGATTCTCAG-3', was reproducibly induced in 
the hippocampus after injection of kainate (Fig. 1A). A sub-
stantial increase in this PCR product was observed 3 h after 
the injection of kainate and persisted for at least another 3 h. 
While the injection of both pentylenetetrazole (PTZ) and cy-
cloheximide (CHX) elicited a moderate increase in the level of 
the PCR product at 3 h, treatment with PTZ alone did not 
produce a significant signal at 45 min in this assay system. 
The 180 bp fragment, which should correspond to the 3'-
end of mRNA, was cloned into the pCRII vector and used for 
Northern blot analysis as a probe (probe E, Fig. 2A). The 
Northern blot showed a marked augmentation in the level 
of this mRNA at 3 and 6 h after kainate injection and a slight 
increase at 3 h following the injection of PTZ and CHX (Fig. 
IB). The mRNA was 6 kb in length and we refer to it as vesl. 
Although no significant change in the levels of vesl was de-
tectable 45 min after the PTZ injection, a moderate increase 
was observed at 45 min when we used a DNA fragment 
(probe D, 1.9 kb) that was 10 times longer than probe E 
(data not shown). Thus, the expression of vesl mRNA in 
the hippocampus was strongly induced by kainate treatment 
2.3. In situ hybridization 
Animals injected with PTZ were deeply anesthetized with pentobar-
bital (50 mg/kg, i.p.). Animals to be examined for the developmental 
expression profile of vesl were anesthetized with diethylether. Anes-
thetized animals were fixed by cardiac perfusion with 4% paraformal-
dehyde in 0.1 M phosphate buffer (pH 7.4)/saline. In situ hybridiza-
tion was carried out as described [19] using a DIG-labeling and 
detection kit (Boehringer Mannheim). DIG-labeled cRNA probe 
was obtained by in vitro transcription. 
2.4. Miscellaneous methods 
Northern blot was carried out as described [19]. Probe DNA was 
labeled with [a-32P]dCTP using a random-primer labeling kit (Strata-
gene). G6PDH cDNA derived from mouse was chosen as a loading 
control because of its constitutive expression [19]. Plaque hybridiza-
tion was performed as described [24] with a ^.ZAPII cDNA library 
constructed from hippocampal RNA of PTZ-treated rats (3 h) [19]. 
The nucleotide sequence was determined on both strands by the di-
deoxy chain-termination method using an automatic DNA sequencer. 
3. Results 
3.1. Identification of a novel gene induced during neuronal 
excitation by mRNA differential display 
We previously observed, using P C R differential display, 
Fig. 1. Increase in the level of vesl mRNA following pharmacologi-
cally induced convulsive seizure. (A) Autoradiograph of a radiola-
beled-PCR differential display with the pair of primers, T12MT and 
5'-GGATTCTCAG-3'. Total cellular RNA was isolated from the 
hippocampal tissue at different times after injection of the drug. An 
arrow indicates the 180 bp PCR product. (B) Northern blot analysis 
of the vesl mRNA. Five ug of hippocampal total RNA was loaded 
onto each lane and hybridized with probe E (see Fig. 2A). The 
same result was obtained when we used probes B and C (not 
shown). Arrow, vesl mRNA of 6 kb. (C) In situ hybridization show-
ing an increase in the vesl mRNA in the hippocampus following 
PTZ administration. DIG-labeled antisense cRNA (probe D, 0.8 ug/ 
|il in hybridization solution) (Fig. 2A) was used. 
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Fig. 2. Primary structure of part of the vesl cDNA and comparison of the predicted amino acid sequence with that of the VASP/Mena family 
of proteins. (A) A physical map of the full-length vesl cDNA. Ec, EcoRl; BX, BstXl; K, Kpnl; Hd, Hindlll; Ps, Pstl. An arrow in the box 
shows the longest ORF. Probes used for Northern analysis and in situ hybridization are also shown. (B) Nucleotide and deduced amino acid 
sequences of the vesl cDNA. In frame-termination codon located upstream of the vesl initiation codon is marked by a double underline. The 
EVHl-like domain is underlined. Putative PKC phosphorylation sites are indicated by asterisks. The conserved PEST sequence is bracketed. 
The PEST scores calculated with the PEST-find algorithm [30,31] are 11.53 (120-152) and 6.60 (152-163). (C) The amino acid sequence of Vesl 
was aligned with the following VASP/Ena family members: Mena and Evl [23], Ena [27] and VASP [28]. Amino acid identities between Vesl 
and other proteins are indicated by white letters in black boxes. Black letters in shadowed boxes represent conserved amino acids. (D) Phyloge-
netic analysis using the UPGMA method [37] revealed that the EVHl-like domain of Vesl (1-113) falls into a distinct evolutionary subgroup 
from that of the EVH1 domain of the VASP/Ena family. 
and moderately by PTZ, confirming the results of differential 
display. 
The regional and temporal expression pattern of vesl 
mRNA in the hippocampus following PTZ injection was ex-
amined more precisely by in situ hybridization (Fig. 1C). Be-
cause of higher sensitivity of in situ hybridization compared to 
Northern blot, the increase in the vesl mRNA level was clearly 
detected in the hippocampus. The induction of vesl mRNA 
was mainly observed in granule cells of the dentate gyrus both 
45 min and 3 h after the injection of PTZ, while only very 
weak induction was seen in the CA1 and CA3 region. 
3.2. Primary structure of vesl mRNA and protein 
A full-length cDNA (5.9 kb in length) was isolated by 
screening an oligo(dT)-primed cDNA library derived from 
the hippocampal RNA of PTZ-treated (3 h) rats [19]. The 
entire nucleotide sequence of the cDNA was determined, 
and we found the existence of a putative open reading frame 
(ORF) of 186 amino acids (20871 Da) (Fig. 2). The sequence 
surrounding the presumptive ATG initiation codon (position 
670) was characteristic of the sequence context of eukaryotic 
initiation codons [25]. The Vesl protein has 6 amino acid 
residues at positions 8, 20, 27, 40, 71 and 174 which could 
serve as phosphorylation sites for protein kinase C [26]. A 
search in the NBRF and Swiss-plot databases revealed that 
the N-terminal region of Vesl (1-113) has significant homol-
ogy (26-30% identical amino acids) to the EVH1 domain (Fig. 
2C), a highly conserved domain among members of the 
VASP/Ena family of proteins (60-70% conservation between 
family members) [23,27,28]. Phylogenetic analysis revealed 
that the EVHl-like region of Vesl lies between the VASP/ 
Ena family of proteins and Wiskott-Aldrich syndrome protein 
(WASP) [29] (Fig. 2D). The putative N-terminal methionine 
of Vesl protein was aligned at the same position as the ini-
tiation methionine of the VASP/Ena family proteins (Fig. 2C), 
supporting that the ATG at position 670 is indeed utilized as 
a translation initiation codon. PEST score analysis revealed 
the existence of a conserved PEST sequence in the C-terminal 
region (Fig. 2B). The PEST sequence is found in proteins with 
high turnover rates and has been postulated to be involved in 
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Fig. 3. HFS delivered to the perforant path induced vesl mRNA expression in the granule cells. Typical photomicrographs of in situ hybridiza-
tion are shown. DIG-labeled vesl cRNA probe (probe A, 12.5 itg/itl in hybridization solution) was hybridized to sections of the dorsal hippo-
campus following LFS (3 h), HFS (45 min), HFS (3 h), or MK801+HFS (3 h) (MK801 was injected 30 min prior to HFS). DG, dentate gyrus; 
CAl, CAl field of the hippocampus. The increase in the level of vesl mRNA is observed in the regions delimited by triangles. The same result 
was obtained with probe D (not shown). 
protein degradation [30,31]. Therefore, the Vesl protein is 
likely to consist of two functional domains, the EVH1 homol-
ogous region at the N-terminus and a putative degradation 
signal at the C-terminus. 
3.3. vesl mRNA was induced during LTP 
We next investigated whether the expression of vesl mRNA 
is regulated during plastic changes in synaptic efficacy. Under 
urethane anesthesia, 5 trains of HFS (400 Hz for 1 s) were 
given to the perforant pathway to elicit LTP in the dentate 
gyrus. This tetanic stimulation usually produced a long-lasting 
enhancement of synaptic transmission measured from the den-
tate gyrus either as the fEPSP slope or as the amplitude of the 
population spike ( > 1 0 h) (Inokuchi, unpublished observa-
tion). Delivery of this tetanic stimulation caused an increase 
in vesl mRNA after 45 min (n = 5) in the dentate gyrus ipsi-
lateral to the stimulation electrode (Fig. 3). The increase was 
maintained at least for 3 h (n - 6). In this experiment, we used 
a higher concentration of cRNA probe (12.5 Ug/ul) compared 
to Fig. 1C (0.8 ug/ul). Thus, basal level of vesl mRNA ex-
pression in the CAl region, which was not observed in Fig. 
1C, could be detected (see also Fig. 4). We found no differ-
ences in the expression profile between LFS control and naive 
rats (compare Figs. 3 and 4), indicating that the chronic im-
plantation of electrode did not affect the expression of vesl 
mRNA. Northern blot analysis using probe F showed an in-
crease in the level of vesl mRNA 3 h after the induction of 
LTP (not shown). 
Among 13 animals that had received the same trains of 
HFS, 2 animals failed to maintain synaptic potentiation for 
unknown reasons. In one case, delivery of HFS caused a 
transient enhancement both in the fEPSP slope and the am-
plitude of population spike. However, the enhancement re-
turned to the baseline level approximately 2 h after HFS. In 
the other case, we did not observe LTP. Analysis of these 
2 animals using in situ hybridization showed no obvious 
vesl signals in the dentate granule cells at 3 h (data not 
shown). Furthermore, administration of the NMDA receptor 
antagonist MK801, which completely prevented the produc-
tion of LTP, also blocked completely the increase in vesl 
mRNA in the granule cells (« = 4) (Fig. 3, see also Fig. 5). 
These results indicate that the induction of vesl expression by 
HFS correlates well with the persistence of LTP, and that the 
expression of vesl mRNA is induced in an NMDA receptor-
dependent manner in the dentate granule cells. 
3.4. Developmental regulation of vesl mRNA expression in the 
rat hippocampus 
We next addressed the question of whether the vesl mRNA 
is expressed during the period of neurogenesis and/or synapto-
genesis. The expression profile of vesl mRNA in the rat hippo-
campus from embryonic day 20 (E20) to the adult was exam-
ined by in situ hybridization (Fig. 4). At E20, a slight vesl 
mRNA signal was located in the subicular area. At P7, the 
level of vesl mRNA became prominent in the CAl^l regions 
and a weak signal was observed in the dentate gyrus. At P14, 
the intensity of the hybridization signal peaked in the CAl^l 
regions, while the weak signal in the dentate gyrus showed no 
appreciable change compared to P7. In the hilus region, most 
of the scattered, large cells, which may be migrating precur-
sors of dentate granule cells, showed moderate hybridization 
signals. By P21, the expression level in the pyramidal cell layer 
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Fig. 4. Expression of the vesl mRNA in the developing hippocampus. Coronal sections of the brain dissected from E20, P7, P14, P21 and adult 
animals were hybridized with a DIG-labeled antisense vesl cRNA probe (probe A, 12.5 ug/ul m hybridization solution). Sense cRNA probe of 
the same concentration was used as a control. DG, dentate gyrus; CAl, CAl field of the hippocampus; S, subiculum. 
had decreased to the adult level. In the dentate gyrus, the 
weak signal was restricted to the ectal blade. In young adults 
(14 weeks), ve.y/-specific labeling of the dentate gyrus had 
faded out to the background level. Thus, the increase in the 
vesl mRNA in the dentate gyrus appears to correspond to a 
particular stage of development, termed synaptogenesis [32]. 
These results suggest an important role for Vesl protein in the 
de novo formation of the synapse. 
induction of the vesl mRNA was closely associated with ac-
tivity-dependent synaptic plasticity in the adult hippocampus. 
The N-terminus of the Vesl protein displays significant ho-
3.5. Tissue distribution of vesl expression in the adult rat 
Northern blot analysis showed absence of significant hy-
bridization signals for vesl in non-neuronal tissues such as 
thymus, lung, heart, liver, spleen, intestine, kidney, testis, 
and skeletal muscle of the adult rat (Fig. 5). 
4. Discussion 
Here we have described a novel gene, vesl, the expression of 
which is enhanced by a pharmacologically induced seizure in 
the hippocampus. This induction was observed even in the 
presence of CHX. Therefore, vesl represents one of the imme-
diate-early genes. The increase in the expression of transcripts 
was also observed during a persistent LTP in the dentate 
granule cells. Preinfusion of MK801 blocked the HFS-induced 
increase in expression, indicating that membrane depolariza-
tion per se is not sufficient for vesl induction. Rather, the 
Fig. 5. The expression of vesl is mainly observed in the LTP-in-
duced hippocampus but not in the other tissues. Northern analysis 
of total RNA prepared from hippocampus and from peripheral tis-
sues. 32P-labeled cDNA (probe A) was used for hybridization. The 
same blots were re-hybridized with the G6PDH probe, which served 
as a loading control. Note that a high background in the top panel 
of the autoradiogram is due to long exposure time (top panel, 24 h; 
bottom, 1 h). 
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mology to the EVHl domain of the VASP/Ena family of 
proteins. Mena, the mammalian homologue of Drosophila En-
abled (End), and VASP are localized at focal contacts in a 
fibroblast cell line and are concentrated in the growth cones 
of the neuron, a highly motile structure at the end of growing 
axons and dendrites [22,23]. Ena is required for proper assem-
bly of axonal structures. The EVHl domain of Mena directly 
binds to zyxin [23], a LIM domain protein that has a role in 
coordinating membrane and cytoskeletal interactions [33]. The 
interaction between Mena and zyxin is important for Mena 
localization at focal contacts [23]. Therefore, it is likely that 
the N-terminal region of Vesl, which comprises an EVHl-like 
domain, targets Vesl to focal contacts and, perhaps, to growth 
cones in neuronal cells. The EVHl domain of VASP/Ena 
family proteins is followed by a proline-rich region that serves 
as a profilin-binding motif. Profilin is an actin-monomer-bind-
ing protein that promotes the formation of F-actin [34,35]. By 
this means, VASP/Ena family proteins function as a structural 
linkage between cytoskeletal proteins, such as actin, and the 
extracellular matrix. Importantly, ectopic expression of the 
neural-enriched isoform of Mena in a fibroblast cell line in-
duces the formation of protuberances enriched in F-actin 
from the cell surface [23]. This implies a role for Mena in 
actin-based extension of filopodia during axonal growth 
cone migration in neuronal cells. 
Instead of a proline-rich motif, Vesl contains a PEST se-
quence associated with the EVHl-like domain. Two funda-
mental characteristics of the Vesl protein, i.e. its inducibility 
during hippocampal LTP and domain structure comprising an 
EVHl-like domain at the N-terminus and a rapid degradation 
signal at the C-terminus, suggest that it might compete with 
other protein(s) that are expressed constitutively and engaged 
in cytoskeletal dynamics. In fact, we have recently isolated a 
novel cDNA encoding a protein that contains an EVHl-like 
domain closely related to that of Vesl and a longer C-terminal 
portion (Kato, Ozawa and Inokuchi, unpublished results). We 
suggest that Vesl may be a dominant negative regulator for a 
component of the adhesion/cytoskeleton apparatus, thereby 
modulating the cytoskeletal dynamics of growth cones in re-
sponse to stimuli that elicits a persistent LTP. 
In neuronal cells, the direction and the pattern of neurite 
growth are determined by the growth cones. The motility of 
the growth cones largely depends on the actin-based struc-
tures, filopodia and lamellipodia. Vesl may function as a 
key effector component that links de novo mRNA and protein 
synthesis, required for the maintenance of LTP, to the mor-
phological changes at synaptic connections, including synapse 
restructuring and increase in the total number of synaptic 
contacts that accompany the maintenance phase of LTP [36]. 
During development of the hippocampus, the expression of 
the vesl transcript reached a maximum during postnatal weeks 
2-3, the period during which neuronal differentiation and 
synaptogenesis extensively occur in the hippocampus [32]. 
Thus, the enhancement of vesl expression was observed not 
only during artificially evoked plastic change in synaptic 
transmission, but also during the developmental construction 
of the neural network. In the developmental stage, neurite 
growth and formation of synapses are substantial steps in 
neuronal differentiation and in the construction of the neural 
network in the brain. It is quite possible to envisage that, in 
some cases, the molecular mechanisms required for neuronal 
plasticity in adulthood are the same as those involved in net-
work formation during the developmental stage. If this were 
the case, then Vesl would play a pivotal role in such a mech-
anism by co-ordinating the construction of neural circuits 
during development and by reorganising neural circuits during 
the acquisition of new information. 
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